A redox-sensitive pathway mediates oxidized LDL-induced downregulation of insulin-like growth factor-1 receptor

Yusuke Higashi1, Tao Peng, Jie Du

  • 1Section of Cardiology, Department of Medicine, Tulane University Health Sciences Center, New Orleans, LA 70112, USA.

Insights

Oxidized low-density lipoprotein (OxLDL) induces apoptosis by downregulating the insulin-like growth factor-1 receptor (IGF-1R) through reactive oxygen species (ROS) production, potentially via lipoxygenase and CD36 pathways.

Area of Science:

  • Cardiovascular Biology
  • Cell Signaling
  • Oxidative Stress

Background:

  • Oxidized low-density lipoprotein (OxLDL) promotes atherosclerosis, partly by inducing apoptosis in vascular cells.
  • OxLDL downregulates insulin-like growth factor-1 receptor (IGF-1R), and IGF-1R overexpression protects against OxLDL-induced apoptosis.

Purpose of the Study:

  • To investigate the signaling pathways by which OxLDL downregulates IGF-1R and induces apoptosis in human aortic smooth muscle cells.
  • To identify the role of reactive oxygen species (ROS) and specific signaling molecules in these OxLDL effects.

Main Methods:

  • Inhibition of extracellular signal-regulated kinase (ERK), p38 mitogen-activated protein kinase (MAPK), and peroxisome proliferator-activated receptor gamma (PPARγ) signaling pathways.
  • Treatment with antioxidants (catalase, superoxide dismutase, Trolox) and lipoxygenase inhibitors (nordihydroguaiaretic acid, AA-861, baicalein).
  • Assessment of IGF-1R expression, apoptosis, and ROS production; use of anti-CD36 antibody.

Main Results:

  • Inhibition of ERK, p38 MAPK, and PPARγ pathways did not prevent OxLDL-induced IGF-1R downregulation or apoptosis.
  • Antioxidants and lipoxygenase inhibitors blocked OxLDL-induced IGF-1R downregulation, apoptosis, and ROS production.
  • Anti-CD36 antibody significantly inhibited OxLDL-induced IGF-1R downregulation, apoptosis, and ROS production.

Conclusions:

  • OxLDL downregulates IGF-1R and induces apoptosis via redox-sensitive pathways, distinct from MAPK and PPARγ signaling.
  • Lipoxygenase activity and ROS production appear critical in mediating these OxLDL effects.
  • A CD36-dependent mechanism may be involved in OxLDL-induced IGF-1R downregulation and apoptosis.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...